Saturday, July 11, 2026

Drug profile · INN

zavegepant

zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — zavegepant
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.

Key facts

INN zavegepant
Mechanism Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist
Target Calcitonin-gene-related peptide receptor, CALCRL/RAMP1

Mechanism of action

Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist

Primary target: Calcitonin-gene-related peptide receptor, CALCRL/RAMP1

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Zavegepant Phase 3 · Pfizer · Migraine

Frequently asked questions

What is zavegepant?

zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.